INS and Insulin resistance: T2DM is a systemic inflammatory disease characterized by insulin resistance or reduced metabolic response to insulin in multiple tissues, including adipose tissue, liver, and skeletal muscle, and by reduced insulin synthesis in pancreatic β-cells [38, 39].